The Efficacy of Single-pill Combination of Olmesartan Medoxomil and Amlodipine Besylate on Office Blood Pressure in Hypertensive Patients who did not Respond to Amlodipine Besylate Monotherapy

CONCLUSION: SPC (OLM 20 mg/AML 5 mg) treatment for 8 weeks was effective in reducing BP, achieving target BP goal, and also improving arterial stiffness in uncontrolled hypertensive patients with AML 5 mg monotherapy.PMID:38152599 | PMC:PMC10751208 | DOI:10.5049/EBP.2023.21.2.45
Source: Electrolyte and Blood Pressure - Category: Internal Medicine Authors: Source Type: research